Daphne van Leeuwen

1.9k total citations
20 papers, 1.5k citations indexed

About

Daphne van Leeuwen is a scholar working on Epidemiology, Immunology and Oncology. According to data from OpenAlex, Daphne van Leeuwen has authored 20 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Immunology and 13 papers in Oncology. Recurrent topics in Daphne van Leeuwen's work include Cytomegalovirus and herpesvirus research (15 papers), Immune Cell Function and Interaction (10 papers) and Viral-associated cancers and disorders (9 papers). Daphne van Leeuwen is often cited by papers focused on Cytomegalovirus and herpesvirus research (15 papers), Immune Cell Function and Interaction (10 papers) and Viral-associated cancers and disorders (9 papers). Daphne van Leeuwen collaborates with scholars based in Netherlands, United Kingdom and France. Daphne van Leeuwen's co-authors include Emmanuel J. H. J. Wiertz, Maaike E. Ressing, Martin Rowe, Ivo P. Touw, Alister C. Ward, Danijela Koppers‐Lalic, Jianmin Zuo, Jaap M. Middeldorp, Jacques Neefjes and John P. de Koning and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Daphne van Leeuwen

20 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daphne van Leeuwen Netherlands 18 849 797 691 233 190 20 1.5k
Neil Blake United Kingdom 23 1.1k 1.3× 1.0k 1.3× 735 1.1× 376 1.6× 381 2.0× 38 2.0k
Misako Yajima Japan 15 566 0.7× 458 0.6× 365 0.5× 210 0.9× 223 1.2× 25 1.1k
Jerome E. Tanner Canada 19 944 1.1× 581 0.7× 530 0.8× 262 1.1× 381 2.0× 34 1.7k
Jacqueline M. Burrows Australia 26 734 0.9× 1.4k 1.7× 542 0.8× 294 1.3× 344 1.8× 36 2.0k
Amy Mauser United States 12 660 0.8× 245 0.3× 298 0.4× 194 0.8× 198 1.0× 12 898
Seiji Maruo Japan 26 1.2k 1.4× 1.1k 1.3× 471 0.7× 535 2.3× 491 2.6× 34 2.1k
Dai Iwakiri Japan 19 955 1.1× 698 0.9× 454 0.7× 578 2.5× 309 1.6× 26 1.8k
Nancy W. Abbey United States 15 1.2k 1.4× 392 0.5× 883 1.3× 272 1.2× 276 1.5× 20 1.9k
Pedro O. de Campos‐Lima Canada 16 550 0.6× 611 0.8× 293 0.4× 201 0.9× 235 1.2× 35 1.2k
Lindsay C. Spender United Kingdom 19 551 0.6× 302 0.4× 368 0.5× 511 2.2× 212 1.1× 28 1.3k

Countries citing papers authored by Daphne van Leeuwen

Since Specialization
Citations

This map shows the geographic impact of Daphne van Leeuwen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daphne van Leeuwen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daphne van Leeuwen more than expected).

Fields of papers citing papers by Daphne van Leeuwen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daphne van Leeuwen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daphne van Leeuwen. The network helps show where Daphne van Leeuwen may publish in the future.

Co-authorship network of co-authors of Daphne van Leeuwen

This figure shows the co-authorship network connecting the top 25 collaborators of Daphne van Leeuwen. A scholar is included among the top collaborators of Daphne van Leeuwen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daphne van Leeuwen. Daphne van Leeuwen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Griffin, Bryan D., Anna M. Gram, Arend Mulder, et al.. (2013). EBV BILF1 Evolved To Downregulate Cell Surface Display of a Wide Range of HLA Class I Molecules through Their Cytoplasmic Tail. The Journal of Immunology. 190(4). 1672–1684. 71 indexed citations
2.
Horst, Daniëlle, W.P. Burmeister, Ingrid G. J. Boer, et al.. (2012). The “Bridge” in the Epstein-Barr Virus Alkaline Exonuclease Protein BGLF5 Contributes to Shutoff Activity during Productive Infection. Journal of Virology. 86(17). 9175–9187. 28 indexed citations
3.
Gent, Michiel van, Bryan D. Griffin, E. G. M. Berkhoff, et al.. (2010). EBV Lytic-Phase Protein BGLF5 Contributes to TLR9 Downregulation during Productive Infection. The Journal of Immunology. 186(3). 1694–1702. 75 indexed citations
4.
Horst, Daniëlle, Daphne van Leeuwen, Nathan P. Croft, et al.. (2009). Specific Targeting of the EBV Lytic Phase Protein BNLF2a to the Transporter Associated with Antigen Processing Results in Impairment of HLA Class I-Restricted Antigen Presentation. The Journal of Immunology. 182(4). 2313–2324. 83 indexed citations
5.
Hislop, Andrew D., Maaike E. Ressing, Daphne van Leeuwen, et al.. (2007). A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates. The Journal of Experimental Medicine. 204(8). 1863–1873. 145 indexed citations
6.
Zuo, Jianmin, Wendy Thomas, Daphne van Leeuwen, et al.. (2007). The DNase of Gammaherpesviruses Impairs Recognition by Virus-Specific CD8+T Cells through an Additional Host Shutoff Function. Journal of Virology. 82(5). 2385–2393. 82 indexed citations
7.
Rowe, Martin, Britt A. Glaunsinger, Daphne van Leeuwen, et al.. (2007). Host shutoff during productive Epstein–Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proceedings of the National Academy of Sciences. 104(9). 3366–3371. 196 indexed citations
8.
Heemskerk, Bianca, Tamara van Vreeswijk, Louise A. Veltrop‐Duits, et al.. (2006). Adenovirus-Specific CD4+ T Cell Clones Recognizing Endogenous Antigen Inhibit Viral Replication In Vitro through Cognate Interaction. The Journal of Immunology. 177(12). 8851–8859. 35 indexed citations
9.
Hassink, Gerco, Danijela Koppers‐Lalic, Daphne van Leeuwen, et al.. (2005). Rat Cytomegalovirus Induces a Temporal Downregulation of Major Histocompatibility Complex Class I Cell Surface Expression. Viral Immunology. 18(4). 607–615. 6 indexed citations
10.
Koppers‐Lalic, Danijela, Eric A. Reits, Maaike E. Ressing, et al.. (2005). Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proceedings of the National Academy of Sciences. 102(14). 5144–5149. 157 indexed citations
11.
Ressing, Maaike E., Sinéad E. Keating, Daphne van Leeuwen, et al.. (2005). Impaired Transporter Associated with Antigen Processing-Dependent Peptide Transport during Productive EBV Infection. The Journal of Immunology. 174(11). 6829–6838. 58 indexed citations
12.
Ressing, Maaike E., Daphne van Leeuwen, Frank A. W. Verreck, et al.. (2004). Epstein-Barr Virus gp42 Is Posttranslationally Modified To Produce Soluble gp42 That Mediates HLA Class II Immune Evasion. Journal of Virology. 79(2). 841–852. 81 indexed citations
13.
Barel, Martine T., Nathalie Pizzato, Daphne van Leeuwen, et al.. (2003). Amino acid composition of α1/α2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11‐mediated down‐regulation. European Journal of Immunology. 33(6). 1707–1716. 41 indexed citations
14.
Barel, Martine T., Maaike E. Ressing, Nathalie Pizzato, et al.. (2003). Human Cytomegalovirus-Encoded US2 Differentially Affects Surface Expression of MHC Class I Locus Products and Targets Membrane-Bound, but Not Soluble HLA-G1 for Degradation. The Journal of Immunology. 171(12). 6757–6765. 70 indexed citations
16.
Ressing, Maaike E., Daphne van Leeuwen, Frank A. W. Verreck, et al.. (2003). Interference with T cell receptor–HLA-DR interactions by Epstein–Barr virus gp42 results in reduced T helper cell recognition. Proceedings of the National Academy of Sciences. 100(20). 11583–11588. 83 indexed citations
17.
Koning, John P. de, Alister C. Ward, Anita M. Schelen, et al.. (2000). STAT3-mediated differentiation and survival of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27Kip1. Oncogene. 19(29). 3290–3298. 112 indexed citations
18.
Ward, Alister C., Judith Gits, Anita M. Schelen, et al.. (1999). Novel Point Mutation in the Extracellular Domain of the Granulocyte Colony-Stimulating Factor (G-Csf) Receptor in a Case of Severe Congenital Neutropenia Hyporesponsive to G-Csf Treatment. The Journal of Experimental Medicine. 190(4). 497–508. 68 indexed citations
19.
Koning, John P. de, Anita M. Schelen, Louise Smith, et al.. (1998). Proliferation Signaling and Activation of Shc, p21Ras, and Myc Via Tyrosine 764 of Human Granulocyte Colony-Stimulating Factor Receptor. Blood. 91(6). 1924–1933. 55 indexed citations
20.
Koning, John P. de, Anita M. Schelen, Louise Smith, et al.. (1998). Proliferation Signaling and Activation of Shc, p21Ras, and Myc Via Tyrosine 764 of Human Granulocyte Colony-Stimulating Factor Receptor. Blood. 91(6). 1924–1933. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026